ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cognitive dysfunction and rheumatoid arthritis (RA)"

  • Abstract Number: 491 • 2018 ACR/ARHP Annual Meeting

    Cognitive Impairment Is Associated with Disease Activity in Patients with Rheumatoid Arthritis

    Wanruchada Katchamart1, Pongthorn Narongroeknawin2, Nattharadee Phutthinart3, Vararak Srinonprasert4, Weerasak Muangpaisan5 and Sumapa Chaiamnuay2, 1Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Thailand, 3Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University,, Bangkok, Thailand, 4Division of Geriatric Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 5Division of Geriatric Medicine, Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, Bangkok, Thailand

    Background/Purpose: Intact cognitive function is important for executing several tasks on day-to-day basis in people with chronic diseases, including rheumatoid arthritis (RA). A number of…
  • Abstract Number: 1516 • 2015 ACR/ARHP Annual Meeting

    Quality Improvement in Elderly Patients with Rheumatoid Arthritis: Pharmacotherapy and Identification of Cognitive Dysfunction

    Brett Smith1 and Kenneth S. O'Rourke2, 1Section on Rheumatology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC, 2Section on Rheumatology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC

    Background/Purpose: Cognitive impairment (CI) casts a significant burden on individuals, caretakers and the US health care system with an estimated prevalence between 10-20%.  While CI…
  • Abstract Number: 2644 • 2015 ACR/ARHP Annual Meeting

    The Relationship Between Disease Activity and Cognitive Impairment in Patients with Rheumatoid Arthritis

    Sang-Il Lee1, Young Sun Suh1, Yun-Hong Cheon1, Hyun-Ok Kim1, Hyun-Su Yang2, Ki-Soo Park2, Eun-Kyoung Park3, Seung-Geun Lee4, Chang-Nam Son5, Ji-Min Kim5 and Sang-Hyon Kim6, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 2Department of Preventive Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Busan National University School of Medicine, Busan, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea, 6Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

    Background/Purpose:  Only few studies investigated the prevalence and risk factors of cognitive impairment in patients with rheumatoid arthritis (RA), however, results are controversial. Therefore we…
  • Abstract Number: 1429 • 2014 ACR/ARHP Annual Meeting

    Systemic Inflammation in Alzheimer’s Disease:  Relevance to Patients with Rheumatoid Arthritis

    M. Elaine Husni1, Colin O'Rourke2, Travis Moore3 and Jagan Pillai4, 1Rheumatology Dept A50, Cleveland Clinic Foundation, Cleveland, OH, 2Quantitative Health Sciences, JJN3-01, Cleveland Clinic, Cleveland, OH, 3ITD Analytics & Reporting - eResearch, Cleveland Clinic, Cleveland, OH, 4Lou Ruvo Center for Brain Health - Neurologic Institute, Cleveland Clinic, Cleveland, OH

    Background/Purpose Alzheimer’s disease (AD) dementia is the most common form of dementia affecting > 25 million people worldwide without known cure.  Research regarding  involvement of…
  • Abstract Number: 1369 • 2014 ACR/ARHP Annual Meeting

    Predictors of Deterioration in Subjective Cognition: Results from a Rheumatoid Arthritis (RA) Observational Cohort Study

    Christine K. Iannaccone1, Jing Cui2, Jonathan S. Coblyn3, Michael Weinblatt4 and Nancy A. Shadick5, 1Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology, Brigham and Womens Hospital, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 4Rheumatology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 5Brigham and Women's Hospital/Harvard University, Cambridge, MA

    Background/Purpose: Previous studies have suggested that RA confers an increased risk for worsened cognition later in life compared with the general population. Research in dementia…
  • Abstract Number: 1580 • 2012 ACR/ARHP Annual Meeting

    The Relationship Between Perceived Cognitive Dysfunction and Objective Neuropsychological Performance in Persons with Rheumatoid Arthritis

    So Young Shin1, Patricia P. Katz2 and Laura J. Julian2, 1Physiological Nursing, University of California San Francisco, San Francisco, CA, 2Medicine, University of California San Francisco, San Francisco, CA

    Background/Purpose: There is an increased appreciation of the burden of cognitive impairment in persons with rheumatoid arthritis (RA). Research shows a gap between perceived cognitive…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology